Innlanz Limited
Innlanz Limited (INL.AX) Stock Overview
Explore Innlanz Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
2.8M
P/E Ratio
-9.96
EPS (TTM)
N/A
ROE
-0.10%
INL.AX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Innlanz Limited (INL.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.01.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -9.96 and a market capitalization of 2.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Innlanz Limited owns and trades a hotel in Hamilton, New Zealand. The company was formerly known as Mediland Pharm Limited and changed its name to Innlanz Limited in November 2021. Innlanz Limited was founded in 2002 and is based in Parramatta, Australia. Innlanz Limited is a subsidiary of Pacific Merchants Group Limited.
Yeshween Mudaliar
18-40 Anderson Street, Parramatta, NSW
2019